VNX001 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.50 enrolled5 locationsNCT06394830
Recruiting
Phase 2
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.120 enrolled14 locationsNCT05737121